| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4001699 | Urologic Oncology: Seminars and Original Investigations | 2007 | 7 Pages |
Abstract
Metastasectomy combined with adjuvant immunotherapy did not result in a significantly higher overall survival rate as compared with metastasectomy alone. Our findings raise the question of “Is there a role of adjuvant immunotherapy after complete metastasectomy in patients with metastatic renal cell carcinoma?”
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Cheol M.D., Yong Hyun M.D., Chang Wook M.D., Sang Eun M.D., Ja Hyeon M.D.,